Methyl 3,6-dibromopyrazine-2-carboxylate

Catalog No. :
ACFVIP743
CAS No. :
13301-04-7
Molecular Formula :
C6H4Br2N2O2
Molecular Weight :
295.92

IUPAC Name:methyl 3,6-dibromopyrazine-2-carboxylate

Methyl 3,6-dibromopyrazine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$81.00Login to see priceIn stockInquiry
100g97%$314.00Login to see priceIn stockInquiry
500g97%$1254.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3,6-dibromopyrazine-2-carboxylate
IUPAC Namemethyl 3,6-dibromopyrazine-2-carboxylate
MDL No.MFCD11976863
Molecular FormulaC6H4Br2N2O2
Molecular Weight295.92
SMILESO=C(C1=NC(Br)=CN=C1Br)OC
InChI KeyOHKYQPNNVGHVOT-UHFFFAOYSA-N
SynonymBCP23260 | SY007908 | AM20070309 | 3,6-Dibromopyrazine-2-carboxylic acid methyl ester | FT-0687601 | DTXSID40670382 | methyl 3,6-dibromopyrazine-2-carboxylate | Q-103335 | SCHEMBL275813 | OHKYQPNNVGHVOT-UHFFFAOYSA-N | 2-PYRAZINECARBOXYLIC ACID, 3,6-DIBROM
CAS No.13301-04-7
PubChem CID45480449

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACFVIP743 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACMULJ620 route compound structure diagram
    ACMULJ620957230-68-1 In Stock
  4. Then
  5. ACFVIP743 route product structure diagram
    ACFVIP74313301-04-7 In Stock
Inquiry

2. ACFVIP743 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOERD563 route compound structure diagram
    ACOERD5636966-01-4 In Stock
  4. Then
  5. ACFVIP743 route product structure diagram
    ACFVIP74313301-04-7 In Stock
Inquiry

Comments (0)